Citadel Advisors - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2018$6,000
-82.4%
26,826
-19.1%
0.00%
Q3 2018$34,000
-17.1%
33,165
+218.9%
0.00%
Q2 2017$41,000
+64.0%
10,400
-43.3%
0.00%
Q4 2016$25,000
-16.7%
18,343
+22.5%
0.00%
Q2 2016$30,00014,9790.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,391,607$1,239,0000.75%
PERKINS CAPITAL MANAGEMENT INC 1,004,550$894,0000.64%
Fairbanks Capital Management, Inc. 234,170$208,0000.24%
DIKER MANAGEMENT LLC 64,365$57,0000.02%
Granahan Investment Management 276,417$246,0000.02%
WEDBUSH SECURITIES INC 52,310$47,0000.01%
Court Place Advisors, LLC 10,000$9,0000.00%
SeaCrest Wealth Management, LLC 11,000$10,0000.00%
Renaissance Technologies 1,068,700$1,317,0000.00%
PANAGORA ASSET MANAGEMENT INC 43,664$39,0000.00%
View complete list of CANCER GENETICS INC shareholders